Not yet recruiting
Thyroid cancer+1
Not yet recruitingStudy of levothyroxine sodium plus liothyronine sodium vs levothyroxine sodium to control TSH in advanced thyroid cancer patients on tyrosine kinase inhibitors
Registered drugNo placebo
Study of levothyroxine sodium plus liothyronine sodium vs levothyroxine sodium to control TSH in advanced thyroid cancer patients on tyrosine kinase inhibitors
Registered drugNo placebo
- Disease:Thyroid cancerHypothyroidism
- Substances:Levothyroxine Sodium
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Levothyroxine Sodium
- Sponsor:Ceinge Biotecnologie Avanzate Franco Salvatore S.c.a.r.l.
